TEAM
Ed Addison
Ed Addison, is CEO of Gunston. He is also Chairman of Cloud Pharmaceuticals, a Research Triangle Park company from Duke University that applies AI to drug discovery and development and has a large pipeline of novel drug candidates. Ed is further a technology adviser to Quantum Venture Management, an evergreen venture fund that focuses on technology and healthcare.
With over 30 years of experience, Ed is on the advisory board or board of directors of a number of companies deploying novel technologies in life sciences, including Valor Diagnostics, Drug Logic, Parallel Profile, PolarisQB, and Quantum Cures Foundation.
With a technical background in Artificial Intelligence and Bioinformatics, and a strong business development and capital raising background, Ed is an industry executive, an adjunct professor, and an established serial entrepreneur of disruptive ventures. Ed has three degrees in engineering (with a focus in bioinformatics and AI), an MBA and a law degree.
Carl Eckstein
Venture capitalist, Mr. Eckstein served as a founder and Managing Director of Next Generation Capital Fund I and Next Generation II venture capital funds; participated in 22 investments, mergers and acquisitions, and replaced the CEOs of three struggling portfolio companies, steering them to successful exits. Initially for IBM and later as a Manager at Price Waterhouse, a principal with Arthur Young and through his own firm, Mr. Eckstein provided professional consulting and technology services to over 250 corporations, federal government and not-for-profit organizations. Among his technology accomplishments, Mr. Eckstein designed the first fully integrated ERP systems for manufacturing for AO Smith, the first Wiki for the Federal Communications Commission, and helped develop the first GIS system for transportation routing. He has lectured at several universities on the investment in early-stage companies. Mr. Eckstein holds a degree in Microbiology from Ohio State University.
Professional Advisors
